Dealmaking In A Downmarket
New research from Corporate Board Member and Shearman & Sterling asked 250 public company directors to weigh in on Covid-19-fueled activism, mergers and takeovers.
Menu
New research from Corporate Board Member and Shearman & Sterling asked 250 public company directors to weigh in on Covid-19-fueled activism, mergers and takeovers.
Survey finds majority of public company directors believe their company is behind on the process of digital transformation—and that could be a good thing.
M&A lawyers share considerations for pursuing deals and seizing buy and sell opportunities post-Covid.
Increasing complexity of the rules and regulations, emerging risk and a lack of formal metrics for measuring the effectiveness of compliance programs are all contributing to rising director anxiety.
Boards are devoting more time to people issues than ever before, but how they approach them—and how directors feel about them—ranges widely.
A King & Spalding legal expert and a seasoned board member and audit chair share their views of what COVID-19 means for companies as we enter earnings season.
Chief Executive Group exists to improve the performance of U.S. CEOs, senior executives and public-company directors, helping you grow your companies, build your communities and strengthen society. Learn more at chiefexecutivegroup.com.